Intra-Hospital Transport of Critically Ill Patients in Intensive Care Unit
- Conditions
- Critical IllnessIntensive Care UnitTransportation Accidents
- Registration Number
- NCT06455696
- Lead Sponsor
- French Society for Intensive Care
- Brief Summary
Intra-hospital transport is a frequent procedure in the ICU, involving patients with the highest severity scores. Although some studies estimate the rate of adverse events to be around 33% during intra-hospital transport, including 4% of serious adverse events, the epidemiological data available is small, heterogeneous, and probably subject to methodological bias.
The aim of this study observational prospective observatoinal study is to determine:
* the different practices existing between ICUs ("practice survey")
* the occurrence of adverse events during intra-hospital transport provided by intensive care units (epidemiological study)
- Detailed Description
This is a multicenter prospective observational study on evaluation of practices between ICUs and to describe the occurence of adverse events during intra-hospital transport provided by ICUs (epidemiological study)
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 645
- Patients aged over 18 years old
- Hospitalized in ICU
- Requiring an intra-hospital transport (e.g imagery, operating room, etc) by the ICU team
- With a departure from ICU and arrival to ICU
- Person under guardianship
- Protected Majors
- Already included in the study
- Transport for an ICU discharge in a medical or surgical ward
- Transport with another team than the ICU team
- Not affiliated to French social security
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events during intra-hospital transport in critical ill patients managed by an ICU team During the intra-intrahospital transport [maximum 3 hours] The number of adverse events during intra-hospital transport managed by an ICU team, as a proportion of the number of transports performed.
- Secondary Outcome Measures
Name Time Method Incidence of non-serious adverse events occurring during intra-hospital transport. During the intra-intrahospital transport [maximum 3 hours] 3) Rate of types of (non-serious) adverse events occurring during intra-hospital transport including O Rate of Withdrawal or mobilization of equipment with low risk of serious complication (e.g. VVP withdrawal, urinary catheter, nasogastric tube, mobilization of endotracheal tube without extubation) O Rate of Non-severe hemodynamic failures (occurrence of arterial hypotension with MAP between 40 and 65 mmHg, or catecholamine increase \< 10% during transport) O Rate of Non-severe respiratory failure (desaturation with a SpO2 ≥ 80%) O Rate of Metabolic failure (e.g. hypoglycemia on return from transport) O Rate of Neurological complications (consciousness disorders occurring without sedation, agitation) O Rate of Material failures (O2 or ventilator failure, electrical syringe pump failure)
Incidence of serious adverse events occurring during intra-hospital transport. During the intra-intrahospital transport [maximum 3 hours] 4) Rate of serious adverse events occurring during intra-hospital transport including O Death O Cardiorespiratory arrest O Accidental extubation and/or need for re-intubation, or removal of high-risk equipment (e.g. central venous catheter, arterial catheter, endotracheal tube) O Severe hemodynamic failure (arterial hypotension with MAP \< 40 mmHg, introduction or increase of catecholamines ≥ 10% during transport) O Severe respiratory failure (desaturation with SpO2 \< 80% or massive inhalation)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
CHU de Strasbourg
🇫🇷Strasbourg, France
CHU de Strasbourg🇫🇷Strasbourg, FranceRaphaël CLERE-JEHLContact+33 1 45 86 51 99raphael.clere@gmail.com